Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Cetuximab can cause unusual hair growth and hair loss.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

PPX causes much less hair loss than traditional taxanes.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

More research is needed to understand chemotherapy-induced hair loss and its phases.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

A man developed alopecia areata after starting cancer treatment with vandetanib.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Promising cancer treatments were found, but the manufacturer closed.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.